Established rheumatoid arthritis treatment follows evidence-based protocols centered on disease-modifying antirheumatic drugs (DMARDs), with GLP-1 medications playing no current role in standard care
Fortino and his clinical team provide expert guidance at every stage of your weight loss and wellness journey
A 2025 systematic review of spanning PubMed, Embase, and Cochrane found GLP-1 receptor agonists deliver HbA1c reductions of 1.52.0% in type 2 diabetes, 724% body weight loss in obesity treatment, and 1420% reduction in major adverse cardiovascular events (Emerging Frontiers in GLP-1 Therapeutics, PMC 2025)
However, this code excludes injections into the laryngeal area - use 64617, 31570, or 31573 for vocal cord treatments instead
rather, it supports the metabolic systems that make weight management possible
Baseline three-chamber testing was performed seven days before pump implantation